Clinical Trial Detail

NCT ID NCT03419130
Title Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

transitional cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.